Guardant Health (GH) Stock Statistics & Valuation Metrics

Guardant Health has a market cap or net worth of $7.53B. The enterprise value is $7.16B.

Guardant Health has 124,705,860 shares outstanding. The number of shares has decreased by -2.65% in one year.

Guardant Health’s return on equity (ROE) is 3.12 and return on invested capital (ROIC) is -34.51%.

The current PE Ratio of Guardant Health is ―. Guardant Health’s PEG ratio is ―.

In the last 12 months, Guardant Health had revenue of 739.02M and earned -436.37M in profits. Earnings per share was -3.56.

In the last 12 months, operating cash flow was -238.55M and capital expenditures -33.18M, giving a free cash flow of -271.73M billion.

Guardant Health pays an annual dividend of ―, resulting in a dividend yield of ―

Guardant Health upcoming earnings date is Oct 30, 2025, After Close (Confirmed).

Guardant Health as a current ratio of 4.68, with Debt / Equity ratio of -428.14%

In the past 12 months, Guardant Health has paid 1.28M in taxes.

Guardant Health EV to EBITDA ratio is -11.69, with an EV/FCF ratio of -16.59.

Guardant Health has $629.14M in cash and marketable securities with $1.33B in debt, giving a net cash position of $705.01M billion.

Gross margin is 62.84%, with operating margin of -60.02%, and net profit margin of -59.05%.

The average price target for Guardant Health is $60.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy